Reversing epithelial to mesenchymal transition by targeted epigenetic editing in breast cancer

Blancafort, Pilar (Investigator 01)
Gersbach, Charles (Investigator 02)
Thompson, Erik (Investigator 03)
Swaminatha Iyer, Iyer (Investigator 04)
Rots, Marianne (Investigator 05)
Redfern, Andrew (Investigator 06)
Chaffer, Christine (Investigator 07)
Cursons, Joseph (Investigator 08)

Status	Finished
Effective start/end date	1/01/18 → 31/12/22

Funding

NHMRC National Health and Medical Research Council : A$1,333,651.00

Access Project

http://purl.org/au-research/grants/nhmrc/1147528

4 Article
2 Review article

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
Waryah, C., Cursons, J., Foroutan, M., Pflueger, C., Wang, E., Molania, R., Woodward, E., Sorolla, A., Wallis, C., Moses, C., Glas, I., Magalhães, L., Thompson, E. W., Fearnley, L. G., Chaffer, C. L., Davis, M., Papenfuss, A. T., Redfern, A., Lister, R. & Esteller, M. & 1 others, Blancafort, P., 4 Aug 2023, In: Advanced Science. 10, 22, 2301802.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Citations (Scopus)
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs
Waryah, C., Alves, E., Mazzieri, R., Dolcetti, R., Thompson, E. W., Redfern, A. & Blancafort, P., Jun 2023, In: Cancers. 15, 12, 3152.
Research output: Contribution to journal › Review article › peer-review

Open Access
2 Citations (Scopus)
Epigenome engineering: new technologies for precision medicine
Sgro, A. & Blancafort, P., 16 Dec 2020, In: Nucleic Acids Research. 48, 22, p. 12453-12482 30 p.
Research output: Contribution to journal › Article › peer-review

Open Access
48 Citations (Scopus)